12.01.2021 12:42:01

Boston Scientific Preliminary Q4 Sales Down Approx. 8.0% On Organic Basis - Quick Facts

(RTTNews) - Boston Scientific Corp. (BSX) reported net sales of approximately $2.71 billion during the fourth quarter of 2020, a decline of approximately 6.8 percent on a reported basis, approximately 8.3 percent on an operational basis and approximately 8.0 percent on an organic basis, year-on-year.

For the full year 2020, Boston Scientific Corp. generated net sales of approximately $9.91 billion, a decline of approximately 7.7 percent on a reported basis, approximately 7.8 percent on an operational basis and approximately 11.3 percent on an organic basis, from previous year.

Analysen zu Boston Scientific Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Boston Scientific Corp. 86,00 1,18% Boston Scientific Corp.